![Timothy Pigot](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Timothy Pigot
Corporate Officer/Principal presso
INHIBIKASE THERAPEUTICS, INC.
Profilo
Timothy J Pigot is Chief Commercial & Strategy Officer at Inhibikase Therapeutics, Inc. since 2025.
Formerly, Mr. Pigot was Chief Commercial Officer at Jade Biosciences, Inc. from 2021 to 2024.
Education includes undergraduate studies at State University of New York at Binghamton.
Posizioni attive di Timothy Pigot
| Società | Posizione | Inizio |
|---|---|---|
| INHIBIKASE THERAPEUTICS, INC. | Corporate Officer/Principal | 19/08/2025 |
Precedenti posizioni note di Timothy Pigot
| Società | Posizione | Fine |
|---|---|---|
| JADE BIOSCIENCES, INC. | Corporate Officer/Principal | 01/08/2024 |
| JADE BIOSCIENCES, INC. | Corporate Officer/Principal | - |
Formazione di Timothy Pigot
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
19
Relazioni di 1° grado
3
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
State University of New York at Binghamton
 State University of New York at Binghamton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inhibikase Therapeutics, Inc.
 Inhibikase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small-molecule kinase inhibitor therapeutics for neurological diseases | Health Technology |
Aerovate Therapeutics, Inc.
 Aerovate Therapeutics, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
